Development of gastroretentive fibrous dosage form for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors - Texts

Home
Main Navigation
Content
Search
Help

Font Standard Bold
Login

Research unit

INNOSUISSE

Project number

106.127.1 IP-LS

Project title

Development of gastroretentive fibrous dosage form for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-

Inserted texts

Category	Text
Short description (German)	Development of gastroretentive fibrous dosage form for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors
Short description (English)	Development of gastroretentive fibrous dosage form for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors
Abstract (German)	We propose the development of a gastroretentive dosage form for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. It is hoped that the dosage form will enable to maintain a steady drug concentration in blood for enhancing efficacy and reducing side effects of cancer therapies.
Abstract (English)	We propose the development of a gastroretentive dosage form for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. It is hoped that the dosage form will enable to maintain a steady drug concentration in blood for enhancing efficacy and reducing side effects of cancer therapies.